Adequacy of endobronchial ultrasound transbronchial needle aspiration samples in the subtyping of non-small cell lung cancer

Lung Cancer

Volumn 80, Issue 1, 2013, Pages 30-34

  Esterbrook, Georgina ^a   Anathhanam, Sujo ^a   Plant, Paul K ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Endobronchial ultrasound transbronchial needle aspiration (EBUS TBNA); Epidermal growth factor receptor (EGFR) testing; Histological subtyping of non small cell lung cancer; Mutation analysis in non small cell lung cancer; Non small cell lung cancer; Non small cell lung cancer not otherwise specified (NSCLC NOS)

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ARTICLE; CANCER STAGING; CYTODIAGNOSIS; ENDOBRONCHIAL ULTRASONOGRAPHY; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; TRANSBRONCHIAL ASPIRATION;

ANTIGENS, CD56; CARCINOMA, NON-SMALL-CELL LUNG; CHROMOGRANINS; DNA MUTATIONAL ANALYSIS; ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE ASPIRATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-5; KERATIN-6; LUNG; LUNG NEOPLASMS; MALE; MUTATION; NEOPLASM METASTASIS; NUCLEAR PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; REPRODUCIBILITY OF RESULTS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84875241154     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2012.12.017     Document Type: Article

References (14)

1. Scagliotti G.V., Parikh P., von Pawel J., Biesma B., Vansteenkiste J., Manegold C., et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. Clin Oncol 2008, 26(21):3543-3551.
2. Mok T.S., Wu Y.L., Thongprasert S., Yang C.H., Chu D.T., Saijo N., et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 2009, 361(10):947-957.
3. [accessed April 2012]. http://www.qiagen.com/products/therascreenegfrpcrkit.aspx.
4. Sharples L.D., Jackson C., Wheaton E., Griffith G., Annema J.T., Dooms C., et al. Clinical effectiveness and cost-effectiveness of endobronchial and endoscopic ultrasound relative to surgical staging in potentially resectable lung cancer: results from the ASTER randomised controlled trial. Health Technol Assess 2012, 16(18):1-75. iii-iv.
5. Lung cancer: the diagnosis and treatment of lung cancer. National Institute of Health and Clinical Excellence (April 2011). Available from http://www.nice.org.uk/lung-cancer-cg121.
6. Ou S.H., Zell J.A. Carcinoma NOS is a common histologic diagnosis and is increasing in proportion among non-small cell lung cancer histologies. J Thorac Oncol 2009, 4(10):1202-1211.
7. NHS Information Centre. National Lung Cancer Audit. [accessed April 2012]. http://www.ic.nhs.uk/webfiles/Services/NCASP/audits%20and%20reports/NHS_IC_Lung_Cancer_AUDIT_2011_Interactive_PDF_V1.0.pdf.
8. Sigel C.S., Moreira A.L., Travis W.D., Zakowski M.F., Thornton R.H., Riely G.J., et al. Subtyping of non-small cell lung carcinoma: a comparison of small biopsy and cytology specimens. J Thorac Oncol 2011, 6(11):1849-1856.
9. Sakr L., Roll P., Payan M.J., Liprandi A., Dutau H., Astoul P., et al. Cytology-based treatment decision in primary lung cancer: is it accurate enough?. Lung Cancer 2012, 75(3):293-299.
10. Wallace W.A., Rassal D.M. Accuracy of cell typing in nonsmall cell lung cancer by EUS/EBUS-FNA cytological samples. Eur Respir J 2011, 38(4):911-917.
11. Righi L., Graziano P., Fornari A., Rossi G., Barbareschi M., Cavazza A., et al. Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine-needle aspiration cytology: a retrospective study of 103 cases with surgical correlation. Cancer 2011, 117(15):3416-3423.
12. Nicholson A.G., Gonzalez D., Shah P., Pynegar M.J., Deshmukh M., Rice A., et al. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis. J Thorac Oncol 2010, 5(4):436-441.
13. Schuurbiers O.C., Looijen-Salamon M.G., Ligtenberg M.J., van der Heijden H.F. A brief retrospective report on the feasibility of epidermal growth factor receptor and KRAS mutation analysis in transesophageal ultrasound- and endobronchial ultrasound-guided fine needle cytological aspirates. J Thorac Oncol 2010, 5(10):1664-1667.
14. Navani N., Brown J.M., Nankivell M., Woolhouse I., Harrison R.N., Jeebun V., et al. Suitability of EBUS-TBNA specimens for subtyping and genotyping of NSCLC: a multi-centre study of 774 patients. Am J Respir Crit Care Med 2012, 185(12):1316-1322.